Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease

doi:10.3748/wjg.v28.i15.1563

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 15

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4859)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

269

WORD

HTML

2619

Figures (1-2)

237

Tables (1-4)

216

Sum=3439

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

375

Download

1045

Sum=1420

Apr 21, 2022 (publication date) through Jun 16, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Apr 21, 2022; 28(15): 1563-1573
Published online Apr 21, 2022. doi: 10.3748/wjg.v28.i15.1563

Full Size Figure Download Figure

Figure 1 Flow diagram of the study population. NAFLD: Nonalcoholic fatty liver disease; FIB-8: Fibrosis-8 score; FIB-4: Fibrosis-4 score; NFS: NAFLD fibrosis score; AASLD: American Association for the Study of Liver Diseases; GGT: Gamma-glutamyl transferase.

Citation: Prasoppokakorn T, Chan WK, Wong VWS, Pitisuttithum P, Mahadeva S, Nik Mustapha NR, Wong GLH, Leung HHW, Sripongpun P, Treeprasertsuk S. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease . World J Gastroenterol 2022; 28(15): 1563-1573
URL: https://www.wjgnet.com/1007-9327/full/v28/i15/1563.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i15.1563